Cite
MLA Citation
Manjusha Hurry et al.. “Cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada.” Journal of medical economics, vol. 19, 2016, pp. 936–944. http://access.bl.uk/ark:/81055/vdc_100035835955.0x000055